<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39366938</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Plekhg5 controls the unconventional secretion of Sod1 by presynaptic secretory autophagy.</ArticleTitle><Pagination><StartPage>8622</StartPage><MedlinePgn>8622</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8622</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52875-5</ELocationID><Abstract><AbstractText>Increasing evidence suggests an essential function for autophagy in unconventional protein secretion (UPS). However, despite its relevance for the secretion of aggregate-prone proteins, the mechanisms of secretory autophagy in neurons have remained elusive. Here we show that the lower motoneuron disease-associated guanine exchange factor Plekhg5 drives the UPS of Sod1. Mechanistically, Sod1 is sequestered into autophagosomal carriers, which subsequently fuse with secretory lysosomal-related organelles (LROs). Exocytosis of LROs to release Sod1 into the extracellular milieu requires the activation of the small GTPase Rab26 by Plekhg5. Deletion of Plekhg5 in mice leads to the accumulation of Sod1 in LROs at swollen presynaptic sites. A reduced secretion of toxic ALS-linked SOD1<sup>G93A</sup> following deletion of Plekhg5 in SOD1<sup>G93A</sup> mice accelerated disease onset while prolonging survival due to an attenuated microglia activation. Using human iPSC-derived motoneurons we show that reduced levels of PLEKHG5 cause an impaired secretion of ALS-linked SOD1. Our findings highlight an unexpected pathophysiological mechanism that converges two motoneuron disease-associated proteins into a common pathway.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hutchings</LastName><ForeName>Amy-Jayne</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hambrecht</LastName><ForeName>Bita</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Veh</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-4558-1329</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giridhar</LastName><ForeName>Neha Jadhav</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0001-6544-4102</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zare</LastName><ForeName>Abdolhossein</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2548-9191</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angerer</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnesorge</LastName><ForeName>Thorben</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schenke</LastName><ForeName>Maren</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5649-591X</Identifier><AffiliationInfo><Affiliation>Institute for Food Quality and Safety, Research Group Food Toxicology and Alternative/Complementary Methods to Animal Experiments, University of Veterinary Medicine Hannover, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomberg School of Public Health, Center for Alternatives to Animal Testing, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Bhuvaneish T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Edinburgh, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6827-1593</Identifier><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Edinburgh, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterneckert</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Regenerative Therapies TU Dresden, Fetscherstr. 105, 01307, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty Carl Gustav Carus of TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeger</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4653-2841</Identifier><AffiliationInfo><Affiliation>Institute for Food Quality and Safety, Research Group Food Toxicology and Alternative/Complementary Methods to Animal Experiments, University of Veterinary Medicine Hannover, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briese</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7137-8260</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stigloher</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6941-2669</Identifier><AffiliationInfo><Affiliation>Imaging Core Facility, Biocenter, University of Würzburg, 97074, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischler</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9288-9481</Identifier><AffiliationInfo><Affiliation>Core Unit Systems Medicine, University of Würzburg, D-97080, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Translational Neurodegeneration Section Albrecht-Kossel, Department of Neurology, University Medical Center Rostock, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock, University Medical Center Rostock, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damme</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9699-9351</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry, Christian-Albrechts-University Kiel, Olshausenstr. 40, 24098, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sendtner</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4737-2974</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lüningschrör</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3883-6554</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany. Lueningsch_P@ukw.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LU 2347/3-1</GrantID><Agency>Deutsche Forschungsgemeinschaft (German Research Foundation)</Agency><Country /></Grant><Grant><GrantID>VORAN-2 16LW066</GrantID><Agency>Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020691">rab GTP-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C511269">Syx protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C522397">PLEKHG5 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005089" MajorTopicYN="N">Exocytosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="Y">Guanine Nucleotide Exchange Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="Y">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017729" MajorTopicYN="N">Presynaptic Terminals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020691" MajorTopicYN="N">rab GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39366938</ArticleId><ArticleId IdType="pmc">PMC11452647</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52875-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52875-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature441, 880–884 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16625205</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature441, 885–889 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Luningschror, P. &amp; Sendtner, M. Autophagy in the presynaptic compartment. Curr. Opin. Neurobiol.51, 80–85 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29549710</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan, V. &amp; Verstreken, P. Autophagy in the presynaptic compartment in health and disease. J. Cell Biol.216, 1895–1906 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496617</ArticleId><ArticleId IdType="pubmed">28515275</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill, S. E. &amp; Colon-Ramos, D. A. The Journey of the Synaptic Autophagosome: A Cell Biological Perspective. Neuron105, 961–973 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32191859</ArticleId></ArticleIdList></Reference><Reference><Citation>Decet, M. &amp; Verstreken, P. Presynaptic Autophagy and the Connection With Neurotransmission. Front. Cell Dev. Biol.9, 790721 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8722708</ArticleId><ArticleId IdType="pubmed">34988081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponpuak, M. et al. Secretory autophagy. Curr. Opin. Cell Biol.35, 106–116 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4529791</ArticleId><ArticleId IdType="pubmed">25988755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, J., Gee, H. Y. &amp; Lee, M. G. Unconventional protein secretion - new insights into the pathogenesis and therapeutic targets of human diseases. J. Cell Sci.131, jcs213686 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29941450</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratta, S. et al., Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular. Int. J. Mol. Sci., 21, 2576 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7178086</ArticleId><ArticleId IdType="pubmed">32276321</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson, P. et al. Abeta secretion and plaque formation depend on autophagy. Cell Rep.5, 61–69 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24095740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, S. et al. Autophagy-Mediated Secretory Pathway is Responsible for Both Normal and Pathological Tau in Neurons. J. Alzheimers Dis.70, 667–680 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31256134</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbidge, K. et al. LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/alpha-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons. Autophagy, 18, 1020–1048 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9196737</ArticleId><ArticleId IdType="pubmed">34612142</ArticleId></ArticleIdList></Reference><Reference><Citation>Trajkovic, K., Jeong, H. &amp; Krainc, D. Mutant Huntingtin Is Secreted via a Late Endosomal/Lysosomal Unconventional Secretory Pathway. J. Neurosci.37, 9000–9012 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5597981</ArticleId><ArticleId IdType="pubmed">28821645</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Garcia, D. et al. A diacidic motif determines unconventional secretion of wild-type and ALS-linked mutant SOD1. J. Cell Biol.216, 2691–2700 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584182</ArticleId><ArticleId IdType="pubmed">28794127</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi, Y. et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain139, 3187–3201 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx, R. et al. Tech: a RhoA GEF selectively expressed in hippocampal and cortical neurons. J. Neurochem92, 850–858 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15686487</ArticleId></ArticleIdList></Reference><Reference><Citation>Luningschror, P. et al. Plekhg5-regulated autophagy of synaptic vesicles reveals a pathogenic mechanism in motoneuron disease. Nat. Commun.8, 678 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5662736</ArticleId><ArticleId IdType="pubmed">29084947</ArticleId></ArticleIdList></Reference><Reference><Citation>Binotti, B. et al. The GTPase Rab26 links synaptic vesicles to the autophagy pathway. Elife4, e05597 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4337689</ArticleId><ArticleId IdType="pubmed">25643395</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Quereda, L. et al. Novel PLEKHG5 mutations in a patient with childhood-onset lower motor neuron disease. Ann. Clin. Transl. Neurol. 8, 294–299 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818229</ArticleId><ArticleId IdType="pubmed">33275839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Z. et al. Novel variants broaden the phenotypic spectrum of PLEKHG5-associated neuropathies. Eur. J. Neurol. 28, 1344–1355 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33220101</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozoguz, A. et al. The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol. Aging36, 1764.e9–18 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6591733</ArticleId><ArticleId IdType="pubmed">25681989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H. J. et al. Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease. Orphanet J. Rare Dis.8, 104 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3728151</ArticleId><ArticleId IdType="pubmed">23844677</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzedine, H. et al. PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease. Hum. Mol. Genet22, 4224–4232 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983407</ArticleId><ArticleId IdType="pubmed">23777631</ArticleId></ArticleIdList></Reference><Reference><Citation>Maystadt, I. et al. The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am. J. Hum. Genet81, 67–76 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950913</ArticleId><ArticleId IdType="pubmed">17564964</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderek, J. PLEKHG5: Merging phenotypes and disease mechanisms in Charcot-Marie-Tooth neuropathy and lower motor neuron disease. Eur. J. Neurol.28, 1106–1107 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33492783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Z. et al. Novel variants broaden the phenotypic spectrum of PLEKHG5-associated neuropathies. Eur. J. Neurol.28, 1344–1355 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33220101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, G. et al. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron108, 822–842 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Luningschror, P. et al. Absence of Plekhg5 Results in Myelin Infoldings Corresponding to an Impaired Schwann Cell Autophagy, and a Reduced T-Cell Infiltration Into Peripheral Nerves. Front. Cell Neurosci.14, 185 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358705</ArticleId><ArticleId IdType="pubmed">32733205</ArticleId></ArticleIdList></Reference><Reference><Citation>Santosa, K. B. et al. Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction. J. Neurosci. Res96, 1125–1135 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292684</ArticleId><ArticleId IdType="pubmed">29536564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabuta, T., Suzuki, Y. &amp; Wada, K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J. Biol. Chem.281, 30524–30533 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16920710</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, L. Y. et al. Molecular immunocytochemistry of the CuZn superoxide dismutase in rat hepatocytes. J. Cell Biol.107, 2169–2179 (1988).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2115655</ArticleId><ArticleId IdType="pubmed">3058718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabouille, C. et al. The differential degradation of two cytosolic proteins as a tool to monitor autophagy in hepatocytes by immunocytochemistry. J. Cell Biol.120, 897–908 (1993).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2200086</ArticleId><ArticleId IdType="pubmed">8432730</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad, L. I. et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl Acad. Sci. USA111, 3620–3625 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Boda, A. et al. Rab26 controls secretory granule maturation and breakdown in Drosophila. Cell Mol. Life Sci.80, 24 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813115</ArticleId><ArticleId IdType="pubmed">36600084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashida, T., Imai, A. &amp; Shimomura, H. Relation of Rab26 to the amylase release from rat parotid acinar cells. Arch. Oral. Biol.51, 89–95 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16076461</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, X. et al. RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation. Mol. Cell Biol.30, 1269–1284 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820885</ArticleId><ArticleId IdType="pubmed">20038531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshie, S. et al. Expression, characterization, and localization of Rab26, a low molecular weight GTP-binding protein, in the rat parotid gland. Histochem Cell Biol.113, 259–263 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10857477</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman, J. M. et al. Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways. Cell Mol. Neurobiol.36, 377–381 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>Solvik, T. A. et al. Secretory autophagy maintains proteostasis upon lysosome inhibition. J. Cell Biol.221, e202110151 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9036093</ArticleId><ArticleId IdType="pubmed">35446347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishi-Itakura, C. et al. Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells. J. Cell Sci.127, 4089–4102 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25052093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi, J. et al. Atg9a deficiency causes axon-specific lesions including neuronal circuit dysgenesis. Autophagy14, 764–777 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070006</ArticleId><ArticleId IdType="pubmed">28513333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M. et al. Translocation of interleukin-1beta into a vesicle intermediate in autophagy-mediated secretion. Elife4, e11205 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728131</ArticleId><ArticleId IdType="pubmed">26523392</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura, E., Kishi-Itakura, C. &amp; Mizushima, N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell151, 1256–1269 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23217709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, X., Teng, J. &amp; Chen, J. New insights regarding SNARE proteins in autophagosome-lysosome fusion. Autophagy17, 2680–2688 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525925</ArticleId><ArticleId IdType="pubmed">32924745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura, T. et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J.36, 42–60 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210154</ArticleId><ArticleId IdType="pubmed">27932448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao, S. K. et al. Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis. J. Biol. Chem.279, 20471–20479 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14993220</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y. X. et al. Lysosomal exocytosis releases pathogenic alpha-synuclein species from neurons in synucleinopathy models. Nat. Commun.13, 4918 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9395532</ArticleId><ArticleId IdType="pubmed">35995799</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky, D. J. et al. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy4, 849–850 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18758232</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre, C. et al. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet17, 119–129 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">17913701</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelen, M. et al. Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis. PLoS One7, e35493 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3335005</ArticleId><ArticleId IdType="pubmed">22536393</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral, D. C. et al. Current methods to analyze lysosome morphology, positioning, motility and function. Traffic23, 238–269 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9323414</ArticleId><ArticleId IdType="pubmed">35343629</ArticleId></ArticleIdList></Reference><Reference><Citation>Binotti, B. et al. ATG9 resides on a unique population of small vesicles in presynaptic nerve terminals. Autophagy20, 883–901 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11062364</ArticleId><ArticleId IdType="pubmed">37881948</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, R. U. &amp; Mills, J. C. RAB26 coordinates lysosome traffic and mitochondrial localization. J. Cell Sci.127, 1018–1032 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937772</ArticleId><ArticleId IdType="pubmed">24413166</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo-Arozena, A. et al. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis. Dis. Model Mech.4, 686–700 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180233</ArticleId><ArticleId IdType="pubmed">21540242</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner, D. et al. Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice. J. Exp. Med.216, 267–278 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363427</ArticleId><ArticleId IdType="pubmed">30635357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel, M. et al. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1. J. Neurosci.36, 1031–1048 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6601999</ArticleId><ArticleId IdType="pubmed">26791230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, W. et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia58, 231–243 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu, I. M. et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep.4, 385–401 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther, R. et al. Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS. Cells11, 1246 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8997900</ArticleId><ArticleId IdType="pubmed">35406813</ArticleId></ArticleIdList></Reference><Reference><Citation>Massih, B. et al. A 3D cell culture system for bioengineering human neuromuscular junctions to model ALS. Front. Cell Dev. Biol.11, 996952 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9973451</ArticleId><ArticleId IdType="pubmed">36866276</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund, S. L. et al. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J. Neurochem.69, 675–681 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9231727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward, L. J. et al. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem.277, 15923–15931 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese, A. et al. M., Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis. Brain146, 3770–3782 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10473564</ArticleId><ArticleId IdType="pubmed">36883643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lie, P. P. Y. et al. Post-Golgi carriers, not lysosomes, confer lysosomal properties to pre-degradative organelles in normal and dystrophic axons. Cell Rep.35, 109034 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135226</ArticleId><ArticleId IdType="pubmed">33910020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee, M. et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat. Med.30, 1771–1783 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11186765</ArticleId><ArticleId IdType="pubmed">38890531</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick, N. D. et al. Distinct roles for motor neuron autophagy early and late in the SOD1(G93A) mouse model of ALS. Proc. Natl Acad. Sci. USA114, E8294–E8303 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweingruber, C. &amp; Hedlund, E. The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis. Biology11, 1191 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9405388</ArticleId><ArticleId IdType="pubmed">36009818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, S. T. et al. PIKFYVE inhibition mitigates disease in models of diverse forms of ALS. Cell186, 786–802.e28 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10062012</ArticleId><ArticleId IdType="pubmed">36754049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers, J. I. et al. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol.131, 103–114 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks, P. et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J. Neurol.256, 234–241 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19252762</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. F. &amp; Wu, Z. Y. Genotype-phenotype correlations of amyotrophic lateral sclerosis. Transl. Neurodegener.5, 3 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster, D. et al. TDP43 aggregates: the ‘Schrodinger’s cat’ in amyotrophic lateral sclerosis. Nat. Rev. Neurosci.22, 514 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34103710</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda, P., Van Den Bosch, L. &amp; Hirth, F. Reply to ‘TDP43 aggregates: the ‘Schrodinger’s cat’ in amyotrophic lateral sclerosis. Nat. Rev. Neurosci.22, 515 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34103711</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz, S. et al. Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol.134, 97–111 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Forssmann, W. G. et al. An improved perfusion fixation method for the testis. Anat. Rec.188, 307–314 (1977).</Citation><ArticleIdList><ArticleId IdType="pubmed">332010</ArticleId></ArticleIdList></Reference><Reference><Citation>Griebel, M. et al. Deep learning-enabled segmentation of ambiguous bioimages with deepflash2. Nat Commun.14, 1679 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10043282</ArticleId><ArticleId IdType="pubmed">36973256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese, S. et al. Isolation and enrichment of embryonic mouse motoneurons from the lumbar spinal cord of individual mouse embryos. Nat. Protoc.5, 31–38 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20057379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science318, 1917–1920 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18029452</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews, N. W. Detection of Lysosomal Exocytosis by Surface Exposure of Lamp1 Luminal Epitopes. Methods Mol. Biol.1594, 205–211 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28456985</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrotis, A. et al. Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells. Autophagy15, 976–997 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526816</ArticleId><ArticleId IdType="pubmed">30661429</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo, F. et al. CDNF rescues motor neurons in models of amyotrophic lateral sclerosis by targeting endoplasmic reticulum stress. Brain146, 3783–3799 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10473573</ArticleId><ArticleId IdType="pubmed">36928391</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal17, 10–12 (2011).</Citation></Reference><Reference><Citation>Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics29, 15–21 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao, Y., Smyth, G. K. &amp; Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics30, 923–930 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>